← Leaderboards
J. Donald Easton
University Of California, San Francisco
$3,901,998
Attributed
$11,705,995
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $23.5M · FY2013–17$25M$18.8M$12.5M$6.3M$0
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$41,041,063 · 2
By mechanism
U01$41,041,063 · 2
Top collaborators
- Jordan J. Elm5 shared
- S. Claiborne Johnston5 shared
- Anthony Suyoung Kim3 shared
Most similar at University Of California, San Francisco
Same institution · by research overlap
- Satya Dandekar$23,346,836
- Mitchell S Elkind$28,705,419
- Diane V Havlir$125,216,731
- Joseph Thomas Giacino$4,115,013
- David O Okonkwo$3,047,456
Others in their field
Top investigators on “Disabled Persons”
- Marco Pahor · Wake Forest University Health Sciences$104,390,649
- David R. Weir · University Of Michigan At Ann Arbor$92,547,475
- Judith Kasper · Johns Hopkins University$79,522,797
- Carol A. Barnes · University Of Arizona$59,754,489
- Vicki A. Freedman · Madlyn/Leonard Abramson Ctr/Jewish Life$58,840,606
- Arie Kapteyn · Rand Corporation$55,366,998
Research focus
Disabled PersonsAfrican AmericanCostData ManagementAspirinAtherothrombosisClopidogrelAntiplatelet DrugsBlindedCollaborationsBlood CoagulationBlood PlateletsBlood VesselsBrain HemorrhageAtrial FibrillationCaringCause Of DeathCerebral IschemiaCessation Of LifeCharacteristicsAcuteClinical ResearchClinical TrialsDose
Grant awards (5)
POINT: PLATELET-ORIENTED INHIBITION IN NEW TIA$11,826,732
U01 · FY2017 · NS
ConProject-001$11,705,995
U01 · FY2017 · NS
POINT: Platelet-Oriented Inhibition in New TIA$3,434,132
U01 · FY2016 · NS · contact PI
POINT: Platelet-Oriented Inhibition in New TIA$7,772,710
U01 · FY2015 · NS · contact PI
POINT: Platelet-Oriented Inhibition in New TIA$6,301,494
U01 · FY2013 · NS · contact PI